SACT 2025 will be held at Mumbai, India from March 6-9, 2025. The SACT 2025 Conference will feature various key programs designed to advance knowledge and practices in cancer care and treatment. The Translational Pathway Program will focus on the latest research and breakthroughs in translational oncology, bridging basic science with clinical application. The Clinical […]

Basic skills in "Strategic Leading and Management in the Cancer Care Continuum" by SPCC will be held from March 7-8, 2025 at Milan, Italy. The leadership and management skills in the Cancer Care Continuum are becoming increasingly important for medical and clinical staff, as they must be prepared to address the challenges, dynamics, and complexity […]

4th How to Diagnose and Treat: CML/MPN will be held at Vienna, Austria from March 7-9, 2025. ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase […]

Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC will be held at Vienna, Austria at 12 March 2025. This activity, supported by Eli Lilly and Company in collaboration with SPCC, was designed to bring together healthcare professionals and innovative organizations to identify gaps in the treatment of Early Breast […]

Join for the first-ever Kidney Cancer Patient Summit on March 15, 2025, at the Alexandria at Torrey Pines organized by the UCSD Moores Cancer Center. This event will bring together patients, caregivers, and experts for a day of learning, networking, and support. Enjoy interactive sessions with specialists, connect with others in the kidney cancer community, […]

EHA Research Conference 2025 will be held at Malaga, Spain from March 17-20. EHA is excited to announce the third edition of the EHA Research Conference, focusing on the theme 'Transcriptional Control and Chromatin Alterations in Normal and Abnormal Hematopoiesis.' Spanning 3.5 days, the conference will provide ample time for in-depth discussions, networking, and social […]